Big pharma firms have paused nearly £2bn in UK investments this year
NegativeWorld Affairs

Big pharmaceutical companies have paused nearly £2bn in planned investments in the UK this year, raising concerns about patient care and job security as the government prepares for talks with Donald Trump over drug pricing.
Editor’s Note: This situation is significant as it highlights the impact of government policies on healthcare investments. The pause in funding could lead to job losses and affect the availability of treatments for patients, making it a critical issue for public health.
— Curated by the World Pulse Now AI Editorial System